Related Experiment Videos
Monoclonal antibodies in immune and inflammatory diseases
Evangelos Andreakos1, Peter C Taylor, Marc Feldmann
1Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, 1 Aspenlea Road, Hammersmith, W6 8LH, London, UK. evangelos.andreakos@ic.ac.uk
Current Opinion in Biotechnology
|December 17, 2002
Abstract:
The era of monoclonal antibody-based therapeutics has arrived. Monoclonal antibodies of high quality targeting almost any antigen can now be engineered and manufactured in large quantities. In the clinic, monoclonal antibodies are proving to be safe and effective for the treatment of a wide range of diseases including rheumatoid arthritis, Crohn's disease, spondyloarthropathies, psoriasis and allograft rejection.